SUSCEPTIBILITY OF 324 NONFERMENTATIVE GRAM-NEGATIVE RODS TO 6 CEPHALOSPORINS AND AZTHREONAM

被引:19
作者
APPELBAUM, PC [1 ]
TAMIM, J [1 ]
PANKUCH, GA [1 ]
ABER, RC [1 ]
机构
[1] PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT MED INFECT DIS,HERSHEY,PA 17033
关键词
D O I
10.1159/000238217
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:337 / 344
页数:8
相关论文
共 20 条
[1]  
[Anonymous], MANUAL CLIN MICROBIO
[2]   4 METHODS FOR IDENTIFICATION OF GRAM-NEGATIVE NON-FERMENTING RODS - ORGANISMS MORE COMMONLY ENCOUNTERED IN CLINICAL SPECIMENS [J].
APPELBAUM, PC ;
STAVITZ, J ;
BENTZ, MS ;
KUSTER, LCV .
JOURNAL OF CLINICAL MICROBIOLOGY, 1980, 12 (02) :271-278
[3]   CEFSULODIN - ANTI-BACTERIAL ACTIVITY AND TENTATIVE INTERPRETIVE ZONE STANDARDS FOR THE DISK SUSCEPTIBILITY TEST [J].
BARRY, AL ;
JONES, RN ;
THORNSBERRY, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 20 (04) :525-529
[4]  
BARRY AL, 1980, MANUAL CLIN MICROBIO
[5]  
FASS RJ, 1980, REV INFECT DIS, V2, P841
[6]   CEFTAZIDIME, A PSEUDOMONAS-ACTIVE CEPHALOSPORIN - INVITRO ANTIMICROBIAL ACTIVITY EVALUATION INCLUDING RECOMMENDATIONS FOR DISK DIFFUSION SUSCEPTIBILITY TESTS [J].
JONES, RN ;
BARRY, AL ;
THORNSBERRY, C ;
GERLACH, EH ;
FUCHS, PC ;
GAVAN, TL ;
SOMMERS, HM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 :187-211
[7]   INVITRO ANTI-BACTERIAL ACTIVITY AND SUSCEPTIBILITY OF CEFSULODIN, AN ANTIPSEUDOMONAL CEPHALOSPORIN, TO BETA-LACTAMASES [J].
KING, A ;
SHANNON, K ;
PHILLIPS, I .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (02) :165-169
[8]   ANTIBACTERIAL ACTIVITY AND BETA-LACTAMASE STABILITY OF CEFTAZIDIME, AN AMINOTHIAZOLYL CEPHALOSPORIN POTENTIALLY ACTIVE AGAINST PSEUDOMONAS-AERUGINOSA [J].
NEU, HC ;
LABTHAVIKUL, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (01) :11-18
[9]   ANTI-BACTERIAL ACTIVITY OF CEFTRIAXONE (RO 13-9904), A BETA-LACTAMASE-STABLE CEPHALOSPORIN [J].
NEU, HC ;
MEROPOL, NJ ;
FU, KP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (03) :414-423
[10]   INVITRO ACTIVITY OF CEFTAZIDIME, A BETA-LACTAMASE STABLE CEPHALOSPORIN [J].
NEU, HC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 :131-134